Hibbing, MN, USA / 93.9 WTBX
Apr 13, 2021 12:18 PM
ROME (Reuters) - The COVID vaccine produced by Johnson & Johnson is important for the fight against coronavirus and will need to be used, Italian Health Minister Roberto Speranza was quoted as saying on Tuesday by Italian news agencies.
The U.S. company said earlier it would delay rolling out the vaccine in Europe after U.S. federal health agencies recommended pausing its use following cases of rare blood clots in six women after they were given it. We will evaluate the situation in the coming days over what will be the best way forward, as soon as the European and American (regulators) give us more formal and definitive news, Speranza was quoted as saying by ADNKronos agency.
Italy health minister says thinks J&J vaccine will have to be used: agency
metro.us - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metro.us Daily Mail and Mail on Sunday newspapers.
AP Story
talkradio1170.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkradio1170.com Daily Mail and Mail on Sunday newspapers.
AP Story
talkradio1170.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkradio1170.com Daily Mail and Mail on Sunday newspapers.
Tanzanian President Dies; Brazil Has Record Cases: Virus Update Bloomberg 4 days ago Bloomberg News © Bloomberg Members of the Mobile Emergency Care Service (SAMU) transfer a patient to a hospital in Bauru, Sao Paulo state, Brazil, on Wednesday, Feb. 24, 2021.
(Bloomberg) Tanzania’s president, a fierce skeptic of the coronavirus pandemic, died at 61. Serbia says it won’t suspend the use of AstraZeneca’s embattled Covid-19 vaccine, which was defended Wednesday by the World Health Organization.
European Commission President Ursula von der Leyen threatened to withhold vaccine exports to the U.K. Almost half of all adults in the U.K. have had a coronavirus vaccine, as the number of first doses administered crossed 25 million.